Exchange: NASDAQ·Updated 07:52 PM EDT

PDSB Earnings

Latest Earnings Results: Q2 '26

Reported: Aug 13

Estimated EPS

-$0.15

Reported EPS

-$0.18

Surprise

-20%

Estimated Rev

$0M

Reported Rev

---

Surprise

---

PDS Biotechnology Corporation reported a net loss of $9.8 million, or $0.18 per basic and diluted share, for the three months ended June 30, 2026, compared to $9.4 million in 2025.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

8-K

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.11
--
--
N/A
Q2 '26
-$0.15
-$0.18
-20.00%
MISSED
Q1 '26
-$0.14
-$0.13
7.14%
BEAT
Q4 '25
-$0.20
-$0.13
35.00%
BEAT
Q3 '25
-$0.20
-$0.19
3.39%
BEAT

Advertisement|Remove ads.